Name:
s41467-022-29801-8.pdf
Size:
1.066Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Pharmacology, College of Medicine, University of ArizonaIssue Date
2022
Metadata
Show full item recordPublisher
Nature ResearchCitation
Cao, X., Li, W., Wang, T., Ran, D., Davalos, V., Planas-Serra, L., Pujol, A., Esteller, M., Wang, X., & Yu, H. (2022). Accelerated biological aging in COVID-19 patients. Nature Communications.Journal
Nature CommunicationsRights
Copyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Chronological age is a risk factor for SARS-CoV-2 infection and severe COVID-19. Previous findings indicate that epigenetic age could be altered in viral infection. However, the epigenetic aging in COVID-19 has not been well studied. In this study, DNA methylation of the blood samples from 232 healthy individuals and 413 COVID-19 patients is profiled using EPIC methylation array. Epigenetic ages of each individual are determined by applying epigenetic clocks and telomere length estimator to the methylation profile of the individual. Epigenetic age acceleration is calculated and compared between groups. We observe strong correlations between the epigenetic clocks and individual’s chronological age (r > 0.8, p < 0.0001). We also find the increasing acceleration of epigenetic aging and telomere attrition in the sequential blood samples from healthy individuals and infected patients developing non-severe and severe COVID-19. In addition, the longitudinal DNA methylation profiling analysis find that the accumulation of epigenetic aging from COVID-19 syndrome could be partly reversed at late clinic phases in some patients. In conclusion, accelerated epigenetic aging is associated with the risk of SARS-CoV-2 infection and developing severe COVID-19. In addition, the accumulation of epigenetic aging from COVID-19 may contribute to the post-COVID-19 syndrome among survivors. © 2022, The Author(s).Note
Open access journalISSN
2041-1723Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1038/s41467-022-29801-8
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License.